Thomas Schenke
Bayer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas Schenke.
Bioorganic & Medicinal Chemistry Letters | 2002
Helmut Haning; Ulrich Niewohner; Thomas Schenke; Mazen Es-Sayed; Gunter Schmidt; Thomas Lampe; Erwin Bischoff
2-aryl-substituted imidazo[5,1-f][1,2,4]triazin-4(3H)-ones represent a new class of potent cGMP-PDE 5 inhibitors that prove to be superior to other purine-isosteric inhibitors. Subnanomolar inhibitors of PDE 5 with activity in in vivo models for erectile dysfunction have been identified. BAY 38-9456 (Vardenafil-hydrochloride) has been selected for clinical studies in the indication of erectile dysfunction.
The Journal of Urology | 2001
Erwin Bischoff; Ulrich Niewoehner; Helmut Haning; M.E.S. Sayed; Thomas Schenke; K.H. Schlemmer
PURPOSE Inhibiting cyclic guanosine monophosphate metabolism may induce penile erection during concomitant nitric oxide production. Vardenafil hydrochloride is a new, highly selective, potent cyclic guanosine monophosphate phosphodiesterase 5 inhibitor. We determined the oral effectiveness of vardenafil in a simple and quantitative conscious rabbit model. MATERIALS AND METHODS Vardenafil was given orally to conscious rabbits. Erection was assessed in a time dependent manner by measuring the length of the uncovered penile mucosa. Erection was evaluated in the absence and presence of intravenous sodium nitroprusside, a nitric oxide donor. RESULTS Vardenafil induced dose dependent penile erection in conscious rabbits after the oral administration of 1 to 30 mg./kg. The efficacy of vardenafil was potentiated and effective doses were significantly reduced by the simultaneous administration of sodium nitroprusside. CONCLUSIONS The effect of vardenafil on penile erection after oral administration was clearly demonstrated in the conscious rabbit model. The time course and early onset of activity indicate that it may be useful for treating erectile dysfunction. Potentiation of the effect by the nitric oxide donor sodium nitroprusside implies that it would have enhanced activity during sexual arousal, when nitric oxide is produced endogenously. The clinical development of this product for erectile dysfunction is proceeding.
Bioorganic & Medicinal Chemistry | 2009
Jens Frackenpohl; Isabelle Adelt; Horst Antonicek; Christian Arnold; Patricia Behrmann; Nicole Blaha; Jutta Böhmer; Oliver Gutbrod; Roman Hanke; Sabine Hohmann; Marc van Houtdreve; Peter Lösel; Olga Malsam; Martin Melchers; Valentina Neufert; Elisabeth Peschel; Udo Reckmann; Thomas Schenke; Hans-Peter Thiesen; Robert Velten; Kathrin Vogelsang; Hans-Christoph Weiss
Starting from natural product podophyllotoxin 1 substituted heterolignans were identified with promising insecticidal in vivo activity. The impact of substitution in each segment of the core structure was investigated in a detailed SAR study, and variation of substituents in both aromatic moieties afforded derivatives 5 and 43 with broad insecticidal activity against lepidopteran and coleopteran species. In vitro measurements supported by modeling studies indicate that heterolignans 3-134 act as tubuline polymerization inhibitors interacting with the colchicine-binding site. Insect specific structure-activity effects were observed showing that the insecticidal SAR described herein differs from reported cytotoxicity studies.
Archive | 2007
Peter Jeschke; Robert Velten; Thomas Schenke; Otto Schallner; Michael Edmund Beck; Rolf Pontzen; Olga Malsam; Udo Reckmann; Ralf Nauen; Ulrich Görgens; Leonardo Pitta; Thomas Müller; Christian Arnold; Erich Sanwald
Archive | 2007
Peter Jeschke; Robert Velten; Thomas Schenke; Otto Schallner; Michael Edmund Beck; Olga Malsam; Ralf Nauen; Thomas Müller; Christian Arnold; Erich Sanwald; Ulrich Görgens
Archive | 1998
Ulrich Niewohner; Mazen Es-Sayed; Helmut Haning; Thomas Schenke; Karl-Heinz Schlemmer; Joerg Keldenich; Erwin Bischoff; Elisabeth Perzborn; Klaus Dembowsky; Peter Serno; Marc Nowakowski
Archive | 1995
Uwe Petersen; Thomas Schenke; Andreas Krebs; Klaus Grohe; Michael Schriewer; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler
Archive | 1992
Uwe Petersen; Andreas Krebs; Thomas Schenke; Thomas Philipps; Klaus Grohe; Klaus-Dieter Bremm; Rainer Endermann; Karl-Georg Dr Metzger; Ingo Haller
Archive | 2007
Peter Jeschke; Robert Velten; Thomas Schenke; Wolfram Andersch; Heike Hungenberg; Wolfgang Thielert
Archive | 1990
Heinz-Jürgen Dr. Bertram; Reiner Fischer; Hermann Hagemann; Bernd-Wieland Krüger; Thomas Schenke; Christoph Erdelen; Birgit Krauskopf; Klaus Lurssen; Hans-Joachim Santel; Robert R. Schmidt; Ulrike Dr. Wachendorff